Form 8-K ALBANY MOLECULAR RESEARC For: Aug 29
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- One killed, three injured when man attacks Swedish school with sword
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
Albany Molecular Research (AMRI) Announces Euticals Acquisition-Related Restructuring Plan
August 29, 2016 4:25 PM EDTAlbany Molecular Research (NASDAQ: AMRI) disclosed the following on Monday:
Item 2.05 Costs Associated with Exit or Disposal Activities.
On August 29, 2016, Albany Molecular Research, Inc. (the Company) announced a restructuring plan with respect to certain operations in the United States and... More
